Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001209191-23-010744 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-17 | 2023-02-15 | FLGT | KIM PAUL | CFO, Treas | F - Tax | $33.99 | -1,340 | 221.0K | -0.6% | -$45.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | F | D | 321 | $33.99 | 222,062 | D | — | — | (F1) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019. |
| 2 | Common | Common Stock | 2023-02-15 | F | D | 1,019 | $33.99 | 221,043 | D | — | — | (F2) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 5, 2019. |